BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2

Immunity

Volumn 17, Issue 4, 2002, Pages 515-524

  Kayagaki, Nobuhiko ^a   Yan, Minhong ^a   Seshasayee, Dhaya ^a   Wang, Hua ^a   Lee, Wyne ^a   French, Dorothy M ^a   Grewal, Iqbal S ^a   Cochran, Andrea G ^a   Gordon, Nathaniel C ^a   Yin, JianPing ^a   Starovasnik, Melissa A ^a   Dixit, Vishva M ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MEMBRANE PROTEIN; PROTEIN; PROTEIN BAFF; PROTEIN P100; PROTEIN P52; RECEPTOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; LIGAND BINDING; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 18644369740     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00425-9     Document Type: Article

References (42)

1. Benhamou L.E., Cazenave P.A., Sarthou P. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20:1990;1405-1407.
2. Bodmer J.L., Schneider P., Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27:2002;19-26.
3. Caamano J.H., Rizzo C.A., Durham S.K., Barton D.S., Raventos-Suarez C., Snapper C.M., Bravo R. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:1998;185-196.
4. Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44:2001;1313-1319.
5. Cochran A.G., Tong R.T., Starovasnik M.A., Park E.J., McDowell R.S., Theaker J.E., Skelton N.J. A minimal peptide scaffold for β-turn display. optimizing a strand position in disulfide-cyclized β-hairpins J. Am. Chem. Soc. 123:2001;625-632.
6. Franzoso G., Carlson L., Poljak L., Shores E.W., Epstein S., Leonardi A., Grinberg A., Tran T., Scharton-Kersten T., Anver M.et al. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:1998;147-159.
7. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109:2002;S81-S96.
8. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
9. Goodnow C.C. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10:1992;489-518.
10. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., Tschopp J., Cachero T.G., Batten M., Wheway J.et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109:2002;59-68.
11. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C.et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:2000;995-999.
12. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., Rixon M., Schou O., Foley K.P., Haugen H.et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease, impaired B cell maturation in mice lacking BLyS. Immunity. 15:2001;289-302.
13. Hahne M., Kataoka T., Schroter M., Hofmann K., Irmler M., Bodmer J.L., Schneider P., Bornand T., Holler N., French L.E.et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188:1998;1185-1190.
14. Hasbold J., Klaus G.G. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20:1990;1685-1690.
15. Hertz M., Nemazee D. Receptor editing and commitment in B lymphocytes. Curr. Opin. Immunol. 10:1998;208-213.
16. Humke E.W., Shriver S.K., Starovasnik M.A., Fairbrother W.J., Dixit V.M. Iceberg. a novel inhibitor of interleukin-1β generation Cell. 103:2000;99-111.
17. Hymowitz S.G., Christinger H.W., Fuh G., Ultsch M., O'Connell M., Kelley R.F., Ashkenazi A., de Vos A.M. Triggering cell death. the crystal structure of Apo2L/TRAIL in a complex with death receptor 5 Mol. Cell. 4:1999;563-571.
18. Kaisho T., Takeda K., Tsujimura T., Kawai T., Nomura F., Terada N., Akira S. IκB kinase α is essential for mature B cell development and function. J. Exp. Med. 193:2001;417-426.
19. Karpusas M., Cachero T.G., Qian F., Boriack-Sjodin A., Mullen C., Strauch K., Hsu Y.M., Kalled S.L. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J. Mol. Biol. 315:2002;1145-1154.
20. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G.et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA. 97:2000;3370-3375.
21. Klinman N.R. The "clonal selection hypothesis" and current concepts of B cell tolerance. Immunity. 5:1996;189-195.
22. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M.P. A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:1993;283-291.
23. Liu Y., Xu L., Opalka N., Kappler J., Shu H.B., Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell. 108:2002;383-394.
24. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies. integrating mammalian biology Cell. 104:2001;487-501.
25. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1999;1697-1710.
26. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D.et al. Blys. member of the tumor necrosis factor family and b lymphocyte stimulator Science. 285:1999;260-263.
27. Naismith J.H., Sprang S.R. Modularity in the TNF-receptor family. Trends Biochem. Sci. 23:1998;74-79.
28. Oren D.A., Li Y., Volovik Y., Morris T.S., Dharia C., Das K., Galperina O., Gentz R., Arnold E. Structural basis of BLyS receptor recognition. Nat. Struct. Biol. 9:2002;288-292.
29. Russell S.J., Cochran A.G. Designing stable β-hairpins. energetic contributions from cross-strand residues J. Am. Chem. Soc. 122:2000;12600-12601.
30. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., Frew E., Scott M.L. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 293:2001;2111-2114.
31. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H.et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189:1999;1747-1756.
32. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C.et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science. 293:2001;1495-1499.
33. Starovasnik M.A., Skelton N.J., O'Connell M.P., Kelley R.F., Reilly D., Fairbrother W.J. Solution structure of the E-domain of Staphylococcal protein A. Biochemistry. 35:1996;15558-15569.
34. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C.et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 293:2001;2108-2111.
35. Xiao G., Harhaj E.W., Sun S.C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell. 7:2001;401-409.
36. Xu S., Lam K.P. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell. Biol. 21:2001;4067-4074.
37. Yamada T., Mitani T., Yorita K., Uchida D., Matsushima A., Iwamasa K., Fujita S., Matsumoto M. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase. J. Immunol. 165:2000;804-812.
38. Yan M., Marsters S.A., Grewal I.S., Wang H., Ashkenazi A., Dixit V.M. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat. Immunol. 1:2000;37-41.
39. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., Cancro M., Grewal I.S., Dixit V.M. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11:2001;1547-1552. a.
40. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., Tumas D., Grewal I.S., Dixit V.M. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2:2001;638-643. b.
41. Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., Schreiber R.D. Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science. 291:2001;2162-2165.
42. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., Bastian H., Kimberly R.P., Zhou T. Cutting edge. a role for B lymphocyte stimulator in systemic lupus erythematosus J. Immunol. 166:2001;6-10.